These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15200479)

  • 1. Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas.
    Lin SC; Chung MY; Huang JW; Shieh TM; Liu CJ; Chang KW
    J Oral Pathol Med; 2004 Jul; 33(6):323-6. PubMed ID: 15200479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis.
    Lin SC; Lo SS; Liu CJ; Chung MY; Huang JW; Chang KW
    J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
    Tu HF; Liu CJ; Chang CS; Lui MT; Kao SY; Chang CP; Liu TY
    J Oral Pathol Med; 2006 Feb; 35(2):99-103. PubMed ID: 16430740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population.
    Chaudhary AK; Pandya S; Mehrotra R; Bharti AC; Jain S; Singh M
    Biomarkers; 2010 Dec; 15(8):684-92. PubMed ID: 20860530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of GST genotypes with age of onset and lymph node metastasis in oral squamous cell carcinoma.
    Liu CJ; Chang CS; Lui MT; Dang CW; Shih YH; Chang KW
    J Oral Pathol Med; 2005 Sep; 34(8):473-7. PubMed ID: 16091114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
    Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
    Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
    Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
    Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
    Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
    Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
    Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
    Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
    Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma.
    Liu CJ; Wong YK; Chang KW; Chang HC; Liu HF; Lee YJ
    J Oral Pathol Med; 2005 Nov; 34(10):608-12. PubMed ID: 16202081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
    Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.